(Q27026262)
Statements
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease? (English)
0 references
23 February 2012
5 references
25 April 2019
28 September 2019
2 October 2019
8 October 2022
5 references
25 April 2019
28 September 2019
2 October 2019
8 October 2022
4 references
25 April 2019
28 September 2019
2 October 2019
8 October 2022
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference